← Open Payments lookup

MAUREEN GENOV: Open Payments

NPI 1396368015 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,514 in 45 payments from 12 companies in 2025. Trend: 2023 $4,761 · 2024 $2,441 · 2025 $1,514

Food & beverage: $1,514
CompanyPaymentsAmount
GENZYME CORPORATION7$430
AstraZeneca Pharmaceuticals LP5$233
Optinose US, Inc.5$178
ARS Pharmaceuticals Operations, Inc.11$146
Novartis Pharmaceuticals Corporation5$128
Genentech USA, Inc.1$122
Takeda Pharmaceuticals U.S.A., Inc.3$93
GlaxoSmithKline, LLC.3$62
Regeneron Healthcare Solutions, Inc.2$40
BioCryst US Sales Co., LLC1$31

Products named: DUPIXENT, TEZSPIRE, Xhance, NEFFY, Xolair, CUVITRU, Rhapsido, TRELEGY ELLIPTA.

Industry payments across TX — which companies pay providers there.